Enhanced ROCK activity on fibroblasts in cardiovascular diseases is responsible for the de novo expression of a pro-fibrotic gene program through the TGF-β, MRTF/serum response factor (SRF) and YAP/TAZ pathways [23]. Here, SRF is linked to cardiovascular disorder.